Correction b5: the devices contained opate084 piperacillin tazobactam 18000mg.The issue was further described as ¿had split on several bags¿ (omitted on initial).Additional information was added to h3, h4, h6 and h10: h4: the device was manufactured from july 11, 2022 - july 13, 2022.H10: the actual device was not available; however, a photograph of the sample was provided for evaluation which only shows three (3) units contained inside a bag.The photograph was visually inspected and showed fluid inside the bag which suggested leaks may have occurred.The reported condition was verified.The cause of the condition could not be determined.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|